FDA clears less-invasive stopped heart system:
This article was originally published in Clinica
CardioThoracic Systems, which manufactures equipment for minimally-invasive cardiac surgery, has received US FDA clearance for a new way of stopping the heart during these procedures. The CTS Voyager Aortic IntraClusion device stops blood flow to the heart through a single incision. The device performs occlusion, arterial perfusion, cardioplegia delivery and aortic venting in a single system, said the Cupertino, California-based company.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.